8 Электронные книги Robert Giffin
Board on Health Sciences Policy & Institute of Medicine: Emerging Safety Science
In recent years, the costs of new drug development have skyrocketed. The average cost of developing a new approved drug is now estimated to be $1.3 billion (Di Masi and Grabowski, 2007). At the same …
PDF
английский
DRM
€42.22
Board on Health Sciences Policy & Institute of Medicine: Breakthrough Business Models
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development …
PDF
английский
DRM
€41.92
Institute of Medicine: Addressing the Threat of Drug-Resistant Tuberculosis
Tuberculosis is one of the leading causes of death in the world today, with 4, 500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is …
PDF
английский
DRM
€45.58
Board on Health Sciences Policy & Institute of Medicine: Accelerating the Development of Biomarkers for Drug Safety
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new …
PDF
английский
DRM
€24.63
Board on Health Sciences Policy & Institute of Medicine: Accelerating the Development of Biomarkers for Drug Safety
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new …
EPUB
английский
DRM
€35.94
Institute of Medicine: Addressing the Threat of Drug-Resistant Tuberculosis
Tuberculosis is one of the leading causes of death in the world today, with 4, 500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is …
EPUB
английский
DRM
€66.71
Board on Health Sciences Policy & Institute of Medicine: Breakthrough Business Models
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development …
EPUB
английский
DRM
€59.71
Board on Health Sciences Policy & Institute of Medicine: Emerging Safety Science
In recent years, the costs of new drug development have skyrocketed. The average cost of developing a new approved drug is now estimated to be $1.3 billion (Di Masi and Grabowski, 2007). At the same …
EPUB
английский
DRM
€59.78
